Furthermore, following separation ofspheroids into CD133+ and CD133− cells, PI3K inhibition withLY294002 reduced the expression of CD133 and Nanog in CD133+ cells fromall sarcoma lines (Suppl. The gene discussed is NANOG; the disease is sarcoma.